Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemic Streptococcus pyogenes M1 UK
Authors:
- Juan Manuel DíazJDJuan Manuel Díaz
- Jasmine E. J. WellsJWJasmine E. J. Wells
- Irene MartinIMIrene Martin
- Allison McGeerAMAllison McGeer
- Matthew A. CroxenMCMatthew A. Croxen
- Gregory J. TyrrellGTGregory J. Tyrrell
- Mark J. WalkerMWMark J. Walker
- Stephan BrouwerSBStephan Brouwer
- John K. McCormickJMJohn K. McCormick
Open Access
- 10 March 2026
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (3) , e0050325
Abstract
Multiple countries have observed an alarming increase in scarlet fever cases, and invasive infections often associated with a new sublineage of Streptococcus pyogenes known as M1 UK . M1 UK strains express increased levels of the streptococcal pyrogenic exotoxin A (SpeA) superantigen, and here we compare the virulence characteristics of this sublineage with the circulating M1 global strain. We obtained contemporary Canadian M1 UK isolates, and genome sequencing revealed that some M1 UK strains had acquired additional DNAse- and superantigen-encoding prophage elements, as well as an isolate with a mutation in covS . Five S . pyogenes strains were chosen for functional experiments, including 5448 (M1 global strain), M1 UK 350 (a “typical” M1 UK strain), M1 UK 162 (M1 UK strain containing a mutation in the covS gene), M1 UK 362 ΦSP1380.vir (M1 UK strain containing a prophage element encoding the spd1 , speC , and ssa genes), and M1 UK 155 Φ370.1 (M1 UK strain containing a prophage element encoding the spd1 and speC genes). Exoprotein profiles demonstrated that all M1 UK background strains had enhanced production of the SpeA superantigen relative to S. pyogenes 5448. Furthermore, strains that had acquired the additional prophage elements showed enhanced activation for human T cells, although cytotoxic activity, adhesion capacity, and DNA degradation were not detectably different. Using a “humanized” superantigen-sensitive HLA-transgenic mouse infection model, the M1 UK 162 covS mutant, and both M1 UK 362 ΦSP1380.vir and M1 UK 155 Φ370.1 strains each demonstrated increased severity during experimental skin infection compared to 5448 and M1 UK 350. These findings indicate that circulating M1 UK background strains continue to acquire additional prophage-encoded virulence factors, or hypervirulent covS mutations, and that these genetic alterations may contribute to increase severity of human infections.Keywords
Funding Information
- Canadian Institutes of Health Research (Project Grant 461623)
- National Health and Medical Research Council
- Fondation Leducq
This publication has 54 references indexed in Scilit:
- Virulence control in group AStreptococcusby a two-component gene regulatory system: Global expression profiling andin vivoinfection modelingProceedings of the National Academy of Sciences, 2002
- Enhanced Susceptibility to Superantigen‐Associated Streptococcal Sepsis in Human Leukocyte Antigen–DQ Transgenic MiceThe Journal of Infectious Diseases, 2001
- Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection CasesInfection and Immunity, 2000
- Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive DiseasesInfection and Immunity, 2000
- THE STRUCTURAL BASIS OF T CELL ACTIVATION BY SUPERANTIGENSAnnual Review of Immunology, 1999
- Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A StreptococcusMolecular Microbiology, 1998
- Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980sThe Lancet, 1992
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenesNew England Journal of Medicine, 1987
- Streptococcal ToxinsClinical Infectious Diseases, 1983